
MSN’s generic drug gets USFDA’s tentative nod
The Hindu
Drugmaker MSN Labs on Thursday said its abbreviated new drug application for a generic version of Cangrelor has received tentative approval from the U.S. Food and Drug Administration (USFDA).The produ
Drugmaker MSN Labs on Thursday said its abbreviated new drug application for a generic version of Cangrelor has received tentative approval from the U.S. Food and Drug Administration (USFDA).
The product will be manufactured at an USFDA and MHRA-approved state-of-the-art injectable facility in Hyderabad, the company said in a release. It is used during percutaneous coronary intervention (PCI) to reduce the risk of blood clots and heart attack.
The USFDA tentative approval comes close on the heels of the company receiving Drugs Controller General of India’s approval for Canreal, its generic version of Cangrelor. “Besides reflecting the capability of MSN Laboratories to deliver products of high-quality standards, this development also provides impetus to our growth aspirations in an important market such as the U.S.,” the company said.

GCCs keep India’s tech job market alive, even as IT services industry embarks on a hiring moratorium
Global Capability Centres, offshore subsidiaries set up by multinational corporations, mostly known by an acronym GCCs, are now the primary engine sustaining India’s tech job market, contrasting sharply with the hiring slowdown witnessed by large firms in the country.

Mobile phones are increasingly migrating to smaller chips that are more energy efficient and powerful supported by specialised Neural Processing Units (NPUs) to accelerate AI workloads directly on devices, said Anku Jain, India Managing Director for MediaTek, a Taiwanese fabless semiconductor firm that claims a 47% market share India’s smartphone chipset market.

In one more instance of a wholly owned subsidiary of a Chinese multinational company in India getting ‘Indianised’, Bharti Enterprises, a diversified business conglomerate with interests in telecom, real estate, financial services and food processing among others, and the local arm of private equity major Warburg Pincus have announced to collectively own a 49% stake in Haier India, a subsidiary of the Haier Group which is headquartered in Qingdao, Shandong, China.










